Prestige Consumer Healthcare Inc

Research Prestige Consumer Healthcare Inc (PBH) on Bullrun: valuation model: 19.0% undervalued, market cap USD 2.28B, P/E 12.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerPBH
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryDrug Manufacturers-Specialty & Generic
CurrencyUSD
Valuation signal19.0% undervalued
Market capUSD 2.28B
P/E12.3
Financial periodFY2026
RevenueUSD 1.09B
Revenue growth-4.3%
Net incomeUSD 190.30M
Free cash flowUSD 246.45M
Gross margin54.7%

Valuation Snapshot

Bullrun's latest valuation model marks Prestige Consumer Healthcare Inc as 19.0% undervalued; latest market cap is USD 2.28B; P/E is 12.3.

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name;

Frequently asked questions

Is Prestige Consumer Healthcare Inc overvalued or undervalued?

Bullrun's valuation model currently marks Prestige Consumer Healthcare Inc as 19.0% undervalued.

What is Prestige Consumer Healthcare Inc's market cap?

Prestige Consumer Healthcare Inc's market capitalization is USD 2.28B.

What is Prestige Consumer Healthcare Inc's P/E ratio?

Prestige Consumer Healthcare Inc's price-to-earnings (P/E) ratio is 12.3.